2021 年 CSANZ 和 ANZSCTS 关于澳大利亚经导管主动脉瓣植入术（TAVI）计划操作人员和机构要求的立场声明。
2021 CSANZ and ANZSCTS Position Statement on the Operator and Institutional Requirements for a Transcatheter Aortic Valve Implantation (TAVI) Program in Australia.
机构信息
Department of Cardiothoracic Surgery, Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, SA, Australia; Department of Surgery, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
Department of Cardiology, Flinders Medical Centre, Southern Adelaide Local Health Network, Adelaide, SA, Australia; Department of Medicine, College of Medicine and Public Health, Flinders University, Adelaide, SA, Australia.
出版信息
Heart Lung Circ. 2021 Dec;30(12):1811-1818. doi: 10.1016/j.hlc.2021.07.017. Epub 2021 Sep 2.
This document establishes the minimum standard for accreditation of institutions and operators as endorsed by the Cardiac Society of Australia and New Zealand (CSANZ) and the Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS). The original Joint Society Position Statement was ratified in August 2014. This 2021 update replaces the original and serves as a consensus within which the Conjoint Committee for Trancatheter Aortic Valve Implantation (TAVI) Accreditation will function, as recommended by Medical Services Advisory Committee (MSAC) Determination for TAVI. This is not a Guideline Statement but takes into consideration regional, legislative, and health system factors important to establishing requirements for TAVI accreditation in Australia.
本文件确立了澳大利亚和新西兰心脏病学会（CSANZ）以及澳大利亚和新西兰心胸外科医师学会（ANZSCTS）认可的机构和操作人员认证的最低标准。最初的联合学会立场声明于 2014 年 8 月获得批准。本 2021 年更新版取代了原版本，作为经医疗服务咨询委员会（MSAC）TAVI 评估建议的经导管主动脉瓣植入（TAVI）认证联合委员会的共识，其中考虑到了澳大利亚 TAVI 认证要求的建立所涉及的区域、立法和卫生系统因素。这不是一个指南声明，但考虑到了在澳大利亚建立 TAVI 认证的要求所涉及的区域、立法和卫生系统因素。
Zotero 插件